TABLE 2.
OUTCOME EVALUATION
| Outcome | Group | Experimental N (%) | Control N (%) | p-value | OR (95% CI)* |
|---|---|---|---|---|---|
| Primary analysis – All randomized women (experimental group N=118, control group N=116) | |||||
| Self-reported Pap testing | All women | 28 (24) | 16 (14) | 0.07 | 1.78 (0.88–3.60) |
| Ever screened women | 20 (31) | 8 (13) | 0.02 | 3.15 (1.20–8.27) | |
| Never screened women | 8 (15) | 8 (15) | 1.00 | 0.85 (0.28–2.58) | |
| Medical records verified Pap testing | All women | 18 (15) | 8 (7) | 0.06 | 2.37 (0.94–5.97) |
| Ever screened women | 13 (20) | 4 (6) | 0.03 | 3.63 (1.06–12.45) | |
| Never screened women | 5 (9) | 4 (8) | 1.00 | 1.00 (0.24–4.19) | |
| Secondary analysis – Women with follow-up data (experimental group N=84, control group N=90) | |||||
| Self-reported Pap testing | All women | 28 (33) | 16 (18) | 0.02 | 2.17 (1.03–4.56) |
| Ever screened women | 20 (43) | 8 (16) | 0.004 | 4.25 (1.50–12.01) | |
| Never screened women | 8 (22) | 8 (21) | 1.00 | 0.80 (0.25–2.60) | |
| Medical records verified Pap testing | All women | 18 (21) | 8 (9) | 0.03 | 2.84 (1.09–7.39) |
| Ever screened women | 13 (28) | 4 (8) | 0.01 | 4.59 (1.28–16.48) | |
| Never screened women | 5 (14) | 4 (10) | 0.73 | 1.17 (0.26-5.30) | |
*
Adjusted for age, education, marital status, years in US, and English proficiency